
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>L56</td><td>1</td><td>Acetylsalicylic acid</td><td>Allopurinol</td><td>The therapeutic efficacy of Allopurinol can be decreased when used in
combination with Acetylsalicylic acid.</td></tr><tr><td>L56</td><td>1</td><td>Acetylsalicylic acid</td><td>Atenolol</td><td>Acetylsalicylic acid may decrease the antihypertensive activities of Atenolol.</td></tr><tr><td>L56</td><td>1</td><td>Atorvastatin</td><td>Atenolol</td><td>Atenolol may decrease the excretion rate of Atorvastatin which could result in a
higher serum level.</td></tr><tr><td>L56</td><td>1</td><td>Barnidipine</td><td>Acetylsalicylic acid</td><td>The risk or severity of hyperkalemia can be increased when Acetylsalicylic acid
is combined with Barnidipine.</td></tr><tr><td>L56</td><td>1</td><td>Barnidipine</td><td>Atenolol</td><td>Atenolol may increase the antihypertensive activities of Barnidipine.</td></tr><tr><td>L56</td><td>1</td><td>Barnidipine</td><td>Atorvastatin</td><td>The metabolism of Atorvastatin can be decreased when combined with Barnidipine.</td></tr><tr><td>L56</td><td>1</td><td>Barnidipine</td><td>Gliclazide</td><td>The risk or severity of hypoglycemia can be increased when Barnidipine is
combined with Gliclazide.</td></tr><tr><td>L56</td><td>1</td><td>Dolutegravir</td><td>Allopurinol</td><td>The excretion of Allopurinol can be decreased when combined with Dolutegravir.</td></tr><tr><td>L56</td><td>1</td><td>Doravirine</td><td>Atorvastatin</td><td>The metabolism of Doravirine can be decreased when combined with Atorvastatin.</td></tr><tr><td>L56</td><td>1</td><td>Doravirine</td><td>Barnidipine</td><td>The metabolism of Doravirine can be decreased when combined with Barnidipine.</td></tr><tr><td>L56</td><td>1</td><td>Ezetimibe</td><td>Atenolol</td><td>Atenolol may decrease the excretion rate of Ezetimibe which could result in a
higher serum level.</td></tr><tr><td>L56</td><td>1</td><td>Gliclazide</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid
is combined with Gliclazide.</td></tr><tr><td>L56</td><td>1</td><td>Gliclazide</td><td>Atenolol</td><td>The therapeutic efficacy of Gliclazide can be increased when used in combination
with Atenolol.</td></tr><tr><td>L56</td><td>1</td><td>Insulin glargine</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid
is combined with Insulin glargine.</td></tr><tr><td>L56</td><td>1</td><td>Insulin glargine</td><td>Atenolol</td><td>The therapeutic efficacy of Insulin glargine can be increased when used in
combination with Atenolol.</td></tr><tr><td>L56</td><td>1</td><td>Insulin glargine</td><td>Barnidipine</td><td>The risk or severity of hypoglycemia can be increased when Barnidipine is
combined with Insulin glargine.</td></tr><tr><td>L56</td><td>1</td><td>Insulin glargine</td><td>Gliclazide</td><td>The risk or severity of hypoglycemia can be increased when Gliclazide is
combined with Insulin glargine.</td></tr><tr><td>L56</td><td>1</td><td>Insulin glargine</td><td>Pioglitazone</td><td>The risk or severity of adverse effects can be increased when Pioglitazone is
combined with Insulin glargine.</td></tr><tr><td>L56</td><td>1</td><td>Insulin glargine</td><td>Ramipril</td><td>The risk or severity of hypoglycemia can be increased when Ramipril is combined
with Insulin glargine.</td></tr><tr><td>L56</td><td>1</td><td>Pioglitazone</td><td>Acetylsalicylic acid</td><td>The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid
is combined with Pioglitazone.</td></tr><tr><td>L56</td><td>1</td><td>Pioglitazone</td><td>Atenolol</td><td>The therapeutic efficacy of Pioglitazone can be increased when used in
combination with Atenolol.</td></tr><tr><td>L56</td><td>1</td><td>Pioglitazone</td><td>Atorvastatin</td><td>The metabolism of Atorvastatin can be decreased when combined with Pioglitazone.</td></tr><tr><td>L56</td><td>1</td><td>Pioglitazone</td><td>Barnidipine</td><td>The metabolism of Pioglitazone can be decreased when combined with Barnidipine.</td></tr><tr><td>L56</td><td>1</td><td>Pioglitazone</td><td>Gliclazide</td><td>The therapeutic efficacy of Gliclazide can be increased when used in combination
with Pioglitazone.</td></tr><tr><td>L56</td><td>1</td><td>Ramipril</td><td>Allopurinol</td><td>The risk of a hypersensitivity reaction to Allopurinol is increased when it is
combined with Ramipril.</td></tr><tr><td>L56</td><td>1</td><td>Ramipril</td><td>Atenolol</td><td>Ramipril may increase the hypotensive activities of Atenolol.</td></tr><tr><td>L56</td><td>1</td><td>Ramipril</td><td>Barnidipine</td><td>Ramipril may increase the antihypertensive activities of Barnidipine.</td></tr></tbody></table></div>
